165 related articles for article (PubMed ID: 22236547)
1. Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms.
Chang MS; Byeon SJ; Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Park KJ
Pathobiology; 2012; 79(1):45-53. PubMed ID: 22236547
[TBL] [Abstract][Full Text] [Related]
2. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
3. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
[TBL] [Abstract][Full Text] [Related]
4. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
5. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
6. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.
O'Connell JT; Tomlinson JS; Roberts AA; McGonigle KF; Barsky SH
Am J Pathol; 2002 Aug; 161(2):551-64. PubMed ID: 12163380
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms.
Yantiss RK; Shia J; Klimstra DS; Hahn HP; Odze RD; Misdraji J
Am J Surg Pathol; 2009 Feb; 33(2):248-55. PubMed ID: 18852679
[TBL] [Abstract][Full Text] [Related]
8. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.
Semino-Mora C; Liu H; McAvoy T; Nieroda C; Studeman K; Sardi A; Dubois A
Ann Surg Oncol; 2008 May; 15(5):1414-23. PubMed ID: 18299935
[TBL] [Abstract][Full Text] [Related]
9. MUC2, MUC5AC and MUC5B in the mucus of a patient with pseudomyxoma peritonei: biochemical and immunohistochemical study.
Mall AS; Chirwa N; Govender D; Lotz Z; Tyler M; Rodrigues J; Kahn D; Goldberg P
Pathol Int; 2007 Aug; 57(8):537-47. PubMed ID: 17610480
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
11. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei.
Lamps LW; Gray GF; Dilday BR; Washington MK
Mod Pathol; 2000 May; 13(5):495-501. PubMed ID: 10824920
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
13. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.
Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM
Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804
[TBL] [Abstract][Full Text] [Related]
14. Mucinous Balls Tangled With Mesothelial Cells and MUC2-Positive Cancer Cells in the Ascites of Pseudomyxoma Peritonei.
Akashi S; Kuwabara H; Yasuda E; Akutagawa H; Takeshita A; Kurisu Y; Egashira Y; Hirose Y; Yuki M; Tsuda Y; Hayashi M
Diagn Cytopathol; 2016 Jul; 44(7):628-31. PubMed ID: 27079739
[TBL] [Abstract][Full Text] [Related]
15. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
Kim D; Jung WH; Koo JS
Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
[TBL] [Abstract][Full Text] [Related]
16. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
[TBL] [Abstract][Full Text] [Related]
17. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
[TBL] [Abstract][Full Text] [Related]
18. Mucinous neoplasms of the appendix and peritoneum.
Panarelli NC; Yantiss RK
Arch Pathol Lab Med; 2011 Oct; 135(10):1261-8. PubMed ID: 21970481
[TBL] [Abstract][Full Text] [Related]
19. Synchronous Ovarian and Appendiceal Mucinous Neoplasms in the Absence of Pseudomyxoma Peritonei.
Gui X; Escobar J; Lee CH; Duggan MA; Köbel M
Int J Gynecol Cancer; 2017 Feb; 27(2):214-222. PubMed ID: 27870702
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
Wang J; El-Bahrawy M
Histopathology; 2015 Mar; 66(4):529-35. PubMed ID: 25298197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
